Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.
about
Identification of cytoplasmic proteins interacting with unliganded estrogen receptor α and β in human breast cancer cellsAberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast CancerClinical significance of estrogen receptor β in breast and prostate cancer from biological aspectsHormone receptor status of contralateral breast cancers: analysis of data from the US SEER population-based registries.Estrogen-Related Factors in the Frontal Lobe of Alzheimer's Disease Patients and Importance of Body Mass Index.Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells.ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFRERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1.Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer.Insufficient antibody validation challenges oestrogen receptor beta research.Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.Combination therapy with anti-DR5 antibody and tamoxifen for triple negative breast cancer.Selective Estrogen Receptor Modulation by Larrea nitida on MCF-7 Cell Proliferation and Immature Rat Uterus.Phosphorylation of estrogen receptor beta at serine 105 is associated with good prognosis in breast cancer.Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis.ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approachesDevelopment of subtype-selective oestrogen receptor-based therapeutics.ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancerDifferential gene expression in tamoxifen-resistant breast cancer cells revealed by a new analytical model of RNA-Seq dataEstrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness-a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancerTamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A-dependent phospho-Akt inactivation in estrogen receptor-negative human breast cancer cellsPrognostic implications of estrogen receptor 1 and vascular endothelial growth factor A expression in primary gallbladder carcinoma.Biologic roles of estrogen receptor-β and insulin-like growth factor-2 in triple-negative breast cancer.Generation of stable reporter breast cancer cell lines for the identification of ER subtype selective ligands.Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifenEstrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells.Unfolding the Role of Stress Response Signaling in Endocrine Resistant Breast Cancers.Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy.PKCα and ERβ Are Associated with Triple-Negative Breast Cancers in African American and Caucasian Patients.Obesity Suppresses Estrogen Receptor Beta Expression in Breast Cancer Cells via a HER2-Mediated PathwayAltered expression of estrogen receptor β2 is associated with different biological markers and clinicopathological factors in papillary thyroid cancerImpact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.Estrogen receptor-beta and breast cancer: translating biology into clinical practicePrognostic significance of full-length estrogen receptor beta expression in stage I-III triple negative breast cancer.PES1 promotes breast cancer by differentially regulating ERα and ERβ.ERβ expression and breast cancer risk prediction for women with atypias.A summary of relationships between alternative splicing and breast cancer.Nuclear estrogen receptor-α expression is an independent predictor of recurrence in male patients with pT1aN0 lung adenocarcinomas, and correlates with regulatory T-cell infiltrationEstrogen receptors and human disease: an update.
P2860
Q24315496-BDCE3FF8-91E5-4961-8932-45BB782A1871Q26773907-F0675DD0-9FDC-4990-A4FA-5E6C0CA8D39EQ28087001-39F82334-E6CF-4801-A808-9A6C934AB500Q31120324-F49FC1B6-4BA4-42C6-BB28-3180B51930DBQ33677902-AEFEC486-EF36-474B-9C8F-008A6FE105EDQ33718203-087326AD-CC13-41A7-8547-23A7CD347A89Q33739387-96482554-3BEB-4DF3-9A5B-CCF2672A199AQ33768248-4D817ED7-36DD-499D-80ED-60D928CBD184Q33866151-75E80FC2-63BB-4C5D-8570-6529046DD787Q33885342-B0026A19-B042-4F3C-9FA1-E21F39C7C870Q33903965-7F562818-66CE-4CA6-9224-3D1612812689Q33989940-E01EF499-3644-454A-83AB-48B49A499807Q34039793-248A36A5-A4DF-4E06-8826-C59B3D6A1B89Q34086835-EF1322F4-B3B5-4CC1-B51A-6DA15181B9DAQ34113589-0778539A-65EC-48D3-BB2B-730292963A39Q34119028-22A19E09-3EE9-4DF5-B974-25A3A38C62BDQ34216817-710B7740-6A1C-4DBA-A87E-C50ECF72872BQ34334131-84D8BD92-8D56-4469-AAF0-6432123CBED7Q34356351-D9C2D898-7CBA-4BFB-BBE1-2F78544D28A1Q34663257-868E2E49-527C-48BA-A324-20122CDDA66FQ34991926-C0A791B5-EDFD-4D84-A901-FFA02BDADBB8Q35000235-E014A785-B7F8-40D1-9103-80D59FE2F3E2Q35012106-84A984CA-CAE9-4E63-B2CB-D96EF7F4D62CQ35271188-AEC0DC70-D5A5-4205-BB80-0BBCF5041C53Q35534361-5859D5A1-8EC4-4303-AA13-458EED3590F8Q35558946-0C78F51F-B36E-43C5-82B3-542C8D1B049DQ35585091-B3A55B21-3C43-4296-9C63-E6871903B1EAQ35763853-1AC78C76-E378-4D54-8A6A-33C7AE177122Q35809680-0F4A2AD7-C036-4611-BDB0-41D410D94943Q35821415-37EE39DD-BD82-481D-8416-87FB81F21B1EQ35879517-1C388CEF-5302-47E0-BE13-3183D400BFA0Q35919319-78BBC1ED-1913-4F2C-B96F-542AEECF1A78Q35931634-260412C9-2C4D-49B6-A226-9B7E35E5F37FQ35973424-ABE1D85E-7B7D-48E5-962E-198FA652FF7EQ35993074-135041E5-826E-469C-8998-9B9127412CE6Q36129096-8DB75085-53F9-46C8-85E6-68CE79400E04Q36248899-23E6C912-4486-49EE-916B-B6F070779832Q36378283-47E2B2EA-F106-4026-AF41-B1F152A9FB20Q36413817-46A7F084-1BC4-4A72-A0F7-5BF51BB39589Q36661810-82B63904-35BA-4069-9703-78A9ACD23C64
P2860
Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Clinical importance of estroge ...... th adjuvant tamoxifen therapy.
@en
type
label
Clinical importance of estroge ...... th adjuvant tamoxifen therapy.
@en
prefLabel
Clinical importance of estroge ...... th adjuvant tamoxifen therapy.
@en
P2093
P356
P1476
Clinical importance of estroge ...... th adjuvant tamoxifen therapy.
@en
P2093
Futoshi Akiyama
Goi Sakamoto
Kaiyo Takubo
Mamoun Younes
Masaaki Matsuura
Naoko Honma
Shigehira Saji
Takuji Iwase
Yoshinori Ito
P304
P356
10.1200/JCO.2007.14.2968
P407
P577
2008-08-01T00:00:00Z